| Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas (NCT05393258) | Washington University School of Medicine | 2022-06-28 |
| Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models (NCT04970615) | Sümeyye Sezer | 2021-05-15 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| Implantable Microdevice In Primary Brain Tumors (NCT04135807) | Oliver Jonas | 2020-03-03 |
| CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma (NCT04047303) | Celgene | 2020-01-02 |
| Pediatric Long-Term Follow-up and Rollover Study (NCT03975829) | Novartis Pharmaceuticals | 2019-11-04 |
| HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors (NCT03911388) | M.D. Anderson Cancer Center | 2019-09-12 |
| Social Determinants of Health in Glioblastoma Population (NCT03900689) | Wake Forest University Health Sciences | 2019-05-22 |
| Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers (NCT03538587) | National Cancer Institute (NCI) | 2019-01-29 |
| Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma (NCT03739372) | University of California, San Francisco | 2018-11-28 |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology (NCT04648462) | Maastricht Radiation Oncology | 2018-01-01 |
| Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma (NCT06620926) | asmaa salama ibrahim | 2018-01-01 |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors (NCT02684058) | Novartis Pharmaceuticals | 2017-12-28 |
| A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 (NCT03152318) | Dana-Farber Cancer Institute | 2017-07-18 |
| Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological Charactersics (NCT03115164) | Centre Hospitalier Universitaire, Amiens | 2017-05-19 |
| TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma (NCT03032484) | The University of Texas Health Science Center at San Antonio | 2017-05-18 |
| GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3) (NCT07673666) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 (NCT07673679) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas (NCT02976441) | Washington University School of Medicine | 2017-01-01 |
| First in Patient Study for PF-06840003 in Malignant Gliomas (NCT02764151) | Pfizer | 2016-09-09 |
| Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors (NCT02747407) | Wake Forest University Health Sciences | 2016-05-01 |
| Nivolumab With DC Vaccines for Recurrent Brain Tumors (NCT02529072) | Gary Archer Ph.D. | 2016-01-01 |
| Radiomics for Prediction of Survival in GBM (NCT02666066) | Maastricht Radiation Oncology | 2016-01-01 |
| Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors (NCT02372409) | Washington University School of Medicine | 2015-08-14 |
| A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas (NCT02209428) | Huashan Hospital | 2014-06-01 |
| Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma (NCT02010606) | Cedars-Sinai Medical Center | 2014-01-08 |
| Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas (NCT01849952) | Dartmouth-Hitchcock Medical Center | 2013-10-09 |
| Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas (NCT01502605) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-01 |
| Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma (NCT01649830) | Sun Yat-sen University | 2012-07-01 |
| Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients (NCT01579253) | Ludwig-Maximilians - University of Munich | 2012-04-01 |
| A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors (NCT01351519) | MultiCare Health System Research Institute | 2011-05-01 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation (NCT01288235) | Massachusetts General Hospital | 2011-02-01 |
| A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 (NCT04327011) | Tocagen Inc. | 2011-02-01 |
| A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB (NCT01125800) | Novartis Pharmaceuticals | 2011-02-01 |
| A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas (NCT01117155) | National Cancer Institute (NCI) | 2010-04-23 |
| A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors (NCT00994071) | National Cancer Institute (NCI) | 2009-09-22 |
| A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma (NCT01044966) | Medical University of South Carolina | 2009-09-01 |
| A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas (NCT00921167) | Clinical Research Center for Solid Tumor, Korea | 2009-06-01 |
| HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas (NCT00874861) | Ian F. Pollack, M.D. | 2009-04-01 |
| Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas (NCT00795457) | Ian F. Pollack, M.D. | 2009-01-01 |
| A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma (NCT00683761) | TransMolecular | 2008-08-01 |
| FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma (NCT01089244) | Ludwig-Maximilians - University of Munich | 2008-06-01 |
| Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma (NCT00591058) | TransMolecular | 2008-02-01 |
| Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) (NCT00624728) | University Hospital, Bordeaux | 2008-02-01 |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma (NCT00389090) | Keryx / AOI Pharmaceuticals, Inc. | 2006-10-01 |
| Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062) (NCT00705198) | Merck Sharp & Dohme LLC | 2006-09-01 |
| Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma (NCT00575887) | Marmara University | 2006-08-01 |
| The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) (NCT00392171) | Merck Sharp & Dohme LLC | 2006-06-09 |
| Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas (NCT00360828) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644) (NCT00335075) | Merck Sharp & Dohme LLC | 2005-03-02 |
| Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma (NCT00154375) | Novartis Pharmaceuticals | 2004-10-01 |
| SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745) (NCT00783393) | Merck Sharp & Dohme LLC | 2003-05-27 |
| Genetic Analysis of Brain Tumors (NCT00031538) | National Cancer Institute (NCI) | 2002-03-01 |
| Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer (NCT00028158) | MediGene | 2001-12-01 |
| Prolonged Daily Temozolomide for Low-Grade Glioma (NCT00165360) | Dana-Farber Cancer Institute | 2001-09-01 |
| Natural History of Patients With Brain and Spinal Cord Tumors (NCT00009035) | National Cancer Institute (NCI) | 2001-01-22 |
| Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor (NCT00001148) | National Institute of Neurological Disorders and Stroke (NINDS) | 1999-10-01 |
| Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors (NCT00179803) | Ann & Robert H Lurie Children's Hospital of Chicago | 1998-03-01 |
| Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma (NCT03722355) | Radiation Therapy Oncology Group | 1990-11-09 |
| A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas (NCT00080054) | Pharmacyclics LLC. | |